Mark Speakman - Concepedia

Author

Mark Speakman

Taunton & Somerset NHS Foundation Trust ORCID

Also Known As

Dr. Mark Speakman, M J Speakman, M Speakman, M. SPEAKMAN, M. Speakman, M.J. Speakman, MARK J. SPEAKMAN, MARK SPEAKMAN, Mark J Speakman, Mark J. Speakman

128

Publications

Citations

H-Index

Concepts

All Affiliations

Taunton & Somerset NHS Foundation Trust Musgrove Park Hospital Somerset NHS Foundation Trust Somerset Hospital Amsterdam UMC Location University of Amsterdam

About

Mark Speakman is an author at Taunton & Somerset NHS Foundation Trust specializing in medicine, urology, and urogynecology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	940
2	Public Health	2	2	27
3	Social Sciences	1	1	75
4	Anatomy	1	1	13
5	Applied Physiology	1	1	49

Mark Speakman

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral resection of the prostate (the UK‐ROPE study) Alistair Ray, John Powell, Mark Speakman, British Journal of Urology	2018	269
Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study Jens Sønksen, Neil Barber, Mark Speakman, European Urology	2015	238
Prostatic urethral lift vs transurethral resection of the prostate: 2‐year results of the <scp>BPH</scp> 6 prospective, multicentre, randomized study Christian Gratzke, Neil Barber, Mark Speakman, British Journal of Urology	2016	195
Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) Stavros Gravas, J.N. Cornu, Mauro Gacci, UrologyBenign Prostatic ObstructionGynecologyBenign Prostatic HyperplasiaUrogynecology	2019	174
Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction K. H ouml fner, H. Claes, T.M. De Reijke, European Urology UrologyBenign Prostatic ObstructionGynecologyBenign Prostatic HyperplasiaUrogynecology	1999	140
A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective &agr; <sub>1A</sub> ‐adrenoceptor antagonist*, in patients with benign prostatic obstruction Paul Abrams, Mark Speakman, M. STOTT, British Journal of Urology	1997	109
Combination Therapy with Solifenacin and Tamsulosin Oral Controlled Absorption System in a Single Tablet for Lower Urinary Tract Symptoms in Men: Efficacy and Safety Results from the Randomised Controlled NEPTUNE Trial Philip Van Kerrebroeck, Christopher R. Chapple, Ted Drogendijk, European Urology Urological ResearchUrologyVoiding DysfunctionMedicineSingle Tablet	2013	102
Guideline for the primary care management of male lower urinary tract symptoms Mark Speakman, Roger Kirby, A.D. Joyce, British Journal of Urology UrologyVoiding DysfunctionRenal PathologyClinical EpidemiologyClinical Trials	2004	97
Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. Grace Dorey, Mark Speakman, R. C. L. FENELEY, PubMed	2004	97
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co‐diagnosis Michael Kirby, Christopher R. Chapple, Graham Jackson, International Journal of Clinical Practice UrologyVoiding DysfunctionHealth PolicySexual And Reproductive HealthInitial Consultation	2013	75

Page 1